Veritas In Silico (TSE:130A) Selling and Marketing Expense : 円0.0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Veritas In Silico's Selling and Marketing Expense for the three months ended in Jun. 2024 was 円0.0 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2024 was 円0.0 Mil.

Veritas In Silico Selling and Marketing Expense Historical Data

The historical data trend for Veritas In Silico's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Selling and Marketing Expense Chart

Veritas In Silico Annual Data

Trend

Dec21

Dec22

Dec23

Selling and Marketing Expense

Veritas In Silico Quarterly Data
	Dec21	Dec22	Sep23	Dec23	Mar24	Jun24
Selling and Marketing Expense	Get a 7-Day Free Trial			-	-	-	-	-

Veritas In Silico Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

Veritas In Silico Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Veritas In Silico Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Selling and Marketing Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031

Website

https://www.veritasinsilico.com

Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines